News

Starpharma and Eli Lilly are working on many projects for the improvement in delivery of small molecule and protein-based pharmaceuticals, with the help of dendrimer technology by Starpharma.

The first randomized double-blind placebo-controlled Phase III Altitude study included patients with type 2 diabetes and renal impairment, to evaluate Rasilez/Tekturna for more than one year in a

iSPERSE is a novel inhaled dry powder delivery platform developed by Pulmatrix for use in the delivery of drugs via inhalation for local or systemic applications. The preclinical

ChemDiv is believed to make use of its expertise in drug discovery. Janssen or Tibotec will fund certain R&D costs of ChemDiv for every research project and ChemDiv

Teriflunomide is an immunomodulatory, disease-modifying oral drug with anti-inflammatory properties, and is under investigation as a treatment for MS. The Tenere trial, which was a two-year, randomized, rater-blinded

Zalicus has drawn the remaining $8.5m from its $20m secured credit facility with Oxford Finance to fund ion channel clinical development. Zalicus CEO Mark Corrigan said they look

According to HUMC’s technology consultant, the US hospital will receive an estimated $8m overall in federal stimulus funds, $3m of that in 2011. The 328-bed hospital will receive

Financial terms of the agreement include an upfront fee, clinical and regulatory milestone payments, and royalties on sales. Under the terms of the agreement, CJ CheilJedang is responsible

ForteBio will provide a range of innovative, label-free protein analysis instruments that will extend Pall’s capabilities in the biopharmaceuticals process monitoring market and in the protein research market.